Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Immucell Cp (ICCC)

Immucell Cp (ICCC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immucell Cp 56 EVERGREEN DR PORTLAND ME 04103 USA

P: 207-878-2770

Description:

ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.

Key Statistics

Overview:

Market Capitalization, $K 43,672
Shares Outstanding, K 7,213
Annual Sales, $ 13,720 K
Annual Net Income, $ -1,300 K
Last Quarter Sales, $ 3,720 K
Last Quarter Net Income, $ -320 K
60-Month Beta 1.15
% of Insider Shareholders 13.90%
% of Institutional Shareholders 8.59%
Float, K 6,210
% Float 86.10%

Growth:

1-Year Return 14.24%
3-Year Return -31.97%
5-Year Return -17.74%
5-Year Revenue Growth 80.53%
5-Year Earnings Growth -216.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/12/20
Earnings Per Share ttm -0.23
EPS Growth vs. Prev Qtr 63.64%
EPS Growth vs. Prev Year 42.86%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-2 on 12/23/04

ICCC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -5.32%
Return-on-Assets % -3.82%
Profit Margin % -9.48
Net Margin % -6.33
Debt/Equity 0.31
Price/Sales 3.03
Price/Cash Flow 42.10
Price/Book 1.54
Book Value/Share 3.89
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar